(Q36970123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17934384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Managing the acutely agitated and psychotic patient (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17934384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Kimberly Nordstrom

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17934384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Michael H Allen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17934384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17934384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17934384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17934384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

10 Suppl 17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17934384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

5-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17934384%20AND%20SRC:MED&resulttype=core&format=json

Heisenberg in the ER: observation appears to reduce involuntary intramuscular injections in a psychiatric emergency service

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

The Overt Aggression Scale for the objective rating of verbal and physical aggression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Treatment of behavioral emergencies: a summary of the expert consensus guidelines

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

A placebo-controlled trial of risperidone in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Laboratory findings in emergently medicated psychiatry patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Who brings patients to the psychiatric emergency room? Psychosocial and psychiatric correlates.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Rapid tranquilization: new approaches in the emergency treatment of behavioral disturbances

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Intramuscular olanzapine in patients with borderline personality disorder: an observational study in an emergency room

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Development of a scale for assessment of agitation following traumatic brain injury

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

What do consumers say they want and need during a psychiatric emergency?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Risperidone in the management of agitation and aggression associated with psychiatric disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Use of restraints and pharmacotherapy in academic psychiatric emergency services

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

The utility of intramuscular ziprasidone in the management of acute psychotic agitation

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Validation of the behavioural activity rating scale (BARS): a novel measure of activity in agitated patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Management of agitation in the acute psychotic patient--efficacy without excessive sedation

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Epidemiology of adult psychiatric visits to US emergency departments

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Best clinical practice with ziprasidone IM: update after 2 years of experience.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Clinical review: agitation and delirium in the critically ill--significance and management

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

Intramuscular aripiprazole in the control of agitation

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

The expert consensus guideline series. Treatment of behavioral emergencies 2005.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900026286

7 January 2021

10.1017/S1092852900026286

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17934384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference